Show simple item record

Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

dc.contributor.authorSolante, R.
dc.contributor.authorAlvarez-Moreno, C.
dc.contributor.authorBurhan, E.
dc.contributor.authorChariyalertsak, S.
dc.contributor.authorChiu, N.-C.
dc.contributor.authorChuenkitmongkol, S.
dc.contributor.authorDo-Van, D.
dc.contributor.authorHwang, K.-P.
dc.contributor.authorKiertiburanakul, S.
dc.contributor.authorLee, P.-I.
dc.contributor.authorLobo, R.C.
dc.contributor.authorMacias, A.
dc.contributor.authorNghia, C.H.
dc.contributor.authorOng-Lim, A.
dc.contributor.authorOrtiz Ibarra, J.
dc.contributor.authorRichtmann, R.
dc.contributor.authorRodriguez-Morales, A.J.
dc.contributor.authorSafadi, M.A.P.
dc.contributor.authorSatari, H.I.
dc.date.accessioned2025-10-31T18:32:40Z
dc.date.available2025-10-31T18:32:40Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4733
dc.description.abstractWe have recently reported a global review of vaccine effec-tiveness (VE) data evaluating almost 80 real-world studies. Atthe time of data extraction (10 February 2022), the vast majorityof studies were limited to two-dose primary vaccination sche-dules and were predominantly conducted before the emergenceof the Omicron variants. To address gaps in the data relating toVE against the Omicron variant, and significantly after the use ofbooster doses, we have already begun to evaluate a more recentdata cut and hope to be able to share that analysis soon...en_US
dc.description.sponsorshipR Solante discloses consulting fees from AstraZeneca. C Alvarez-Moreno discloses grants from WHO solidarity COVID-19 vaccine studies, and speaker from GSK, Pfizer, Astra Zeneca. E Burhan, KP Hwang, A Macia, CH Nghia, JO Ibarra, HI Satari, A Rodriguez-Morales and S Chariyalertsak disclose consulting fees from AstraZeneca. NC Chiu discloses consulting fees from AstraZeneca and honoraria for scientific meeting travel and lecture from multiple companies. He is also a member of the Taiwan Vaccine Injury Compensation Program and Pediatric Infectious Disease Society of Taiwan. DV Dung discloses consulting fees and honoraria for advisory board attendance by AstraZeneca. S Kiertiburanakul discloses consulting fees from AstraZeneca and honoraria for lectures from AstraZeneca, Pfizer and Zuellig Pharma. PI Lee discloses grants from the Taiwan Center for Disease Control for COVID-19 vaccine immunogenicity studies, consulting fees from AstraZeneca, Merck Sharp & Dohme (MSD), and GlaxoSmithKline and payment for lectures from MSD. He also serves as the Chair, Advisory Committee on Immunization Practice in Taiwan. RC Lobo discloses consulting fees from AstraZeneca and honoraria for lectures from Menarini Philippines, Nestle, Mead Johnson and Novartis. He is also the vice-chair of the National Adverse Events Following Immunization committee in the Philippines. A Ong-Lim discloses honoraria for lectures from Moderna and is a member of the Technical Advisory Group, Department of Health in the Philippines. R Richtmann discloses consulting fees from AstraZeneca and honoraria for lectures from Pfizer and J&J. MAP Safadi discloses research grants and consultancy fees from Pfizer, GlaxoSmithKline, MSD, AstraZeneca, Janssen, and Sanofi-Pasteur.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherTaylor and Francis
dc.relation.ispartofurn:issn:1744-8395
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectCOVID-19, Its Impact, and Vaccinationen_US
dc.subjectVaccine Efficacy and Immune Response in COVID-19en_US
dc.titleFurther implications on the global real-world vaccine effectiveness against SARS-CoV-2en_US
dc.typehttps://purl.org/coar/resource_type/c_545b
dc.identifier.doihttps://doi.org/10.1080/14760584.2022.2110073
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.08
dc.type.otherLetter to the editor
dc.identifier.journalExpert Review of Vaccines
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2